Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-09

Clinical Trial Update: Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oat beta-glucan as a supplement in Chilean patients with Type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oat beta-glucan (beta-glucan from oats)

Snippet

Sponsor: Centro de Estudios en Alimentación y Nutrición, Chile | Conditions: Type2 Diabetes | Phase 2 | Status: COMPLETED